Transcription of Annual Report 2017 - leo-pharma.com
{{id}} {{{paragraph}}}
LEO Pharma A/S Annual Report2 017125,000 employees, incl. more than 700 scientists and specialists61 Presence in 61 countries15% of revenue is invested in research and development19 0 8 Founded in 1908 and headquartered in DenmarkPatients first. Always. LEO Pharma is a global leader in medical dermatology, dedicated to helping people achieve healthy skin. Together with our partners, we advance science and develop life-changing medicines which improve people s lives. Being ultimately owned by the LEO Foundation, we are first and foremost account-able to patients. As we have no external shareholders, all profits are reinvested in the LEO Group. We focus on patient needs and do what is right for the long focus on skin diseases with a high unmet need for treatment, including rare skin diseases.
6 7 7 LEO Pharma Annual Report 2017 CEO letter A clear direction 2017 as a ery ood year for LEO Pharma e helped 80 million patients, 7 million more than the year before,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}